General Information of Drug (ID: DM8OYZB)

Drug Name
Imepitoin
Synonyms ADD-233089; AWD-131-138
Indication
Disease Entry ICD 11 Status REF
Convulsion 8A68.Z Discontinued in Phase 1 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 279.72
Logarithm of the Partition Coefficient (xlogp) 1.2
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C13H14ClN3O2
IUPAC Name
3-(4-chlorophenyl)-5-morpholin-4-yl-4H-imidazol-2-one
Canonical SMILES
C1COCCN1C2=NC(=O)N(C2)C3=CC=C(C=C3)Cl
InChI
InChI=1S/C13H14ClN3O2/c14-10-1-3-11(4-2-10)17-9-12(15-13(17)18)16-5-7-19-8-6-16/h1-4H,5-9H2
InChIKey
IQHYCZKIFIHTAI-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
3083511
CAS Number
188116-07-6
TTD ID
D06BYS
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Translocator protein (TSPO) TTPTXIN TSPO_HUMAN Agonist [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008368)
2 The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy. CNS Drugs. 2014 Jan;28(1):29-43.